Meeting
2023 ASCO Breakthrough
The efficacy of boron neutron capture therapy with folate receptor targeted novel boron carrier in F98 rat brain tumor models.
Authors
Kohei Tsujino
Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
Kohei Tsujino , Shinji Kawabata , Hideki Kashiwagi , Ryo Kayama , Yoshiki Fujikawa , Yusuke Fukuo , Ryo Hiramastu , Toshihiro Takami , Shin-Ichi Miyatake , Naonori Hu , Takushi Takata , Hiroki Tanaka , Minoru Suzuki , Kai Nishimura , Hiroyuki Nakamura , Masahiko Wanibuchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Hematologic Malignancies,Thoracic Cancers,Other Malignancies or Topics
Sub Track
Other Technology and Innovations
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 21)
DOI
10.1200/GO.2023.9.Supplement_1.21
Abstract #
21
Poster Bd #
C5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Potential for boron neutron capture therapy (BNCT) with ASCT2-targeted boron agents.
First Author: Kenichiro Eza
Poster
2020 ASCO Virtual Scientific Program
Clinical efficacy of ONC201 in thalamic H3 K27M-mutant glioma.
First Author: Abed Rahman Kawakibi
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Yoga program for patients with brain tumors undergoing radiotherapy (XRT) and their family caregivers.
First Author: Kathrin Milbury
Poster
2014 ASCO Annual Meeting
Oncolytic viral therapy for malignant gliomas using myxoma virus deleted for antiapoptotic M11L gene.
First Author: Peter A. J. Forsyth